Загрузка...

Combination therapy with pulmonary arterial hypertension targeted drugs and immunosuppression can be a useful strategy for sarcoidosis-associated pulmonary hypertension: a case report

BACKGROUND: Pulmonary hypertension (PH) is one of the significant complications of sarcoidosis. In the clinical classification of PH proposed in the recent world symposium of PH 2018, sarcoidosis-associated PH is classified in Group 5. The mechanisms of sarcoidosis-associated PH are very heterogeneo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eur Heart J Case Rep
Главные авторы: Sumimoto, Keiko, Taniguchi, Yu, Emoto, Noriaki, Hirata, Ken-Ichi
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850610/
https://ncbi.nlm.nih.gov/pubmed/33554014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcr/ytaa454
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!